Biote Corp Stock Fundamentals
| BTMD Stock | USD 6.10 0.10 1.61% |
biote Corp fundamentals help investors to digest information that contributes to Biote Corp's financial success or failures. It also enables traders to predict the movement of Biote Stock. The fundamental analysis module provides a way to measure Biote Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biote Corp stock.
At present, Biote Corp's Selling And Marketing Expenses is projected to decrease significantly based on the last few years of reporting. The current year's Operating Income is expected to grow to about 27.1 M, whereas Depreciation And Amortization is forecasted to decline to about 1.9 M. Biote | Select Account or Indicator |
biote Corp Company Current Valuation Analysis
Biote Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Biote Corp Current Valuation | 276.98 M |
Most of Biote Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, biote Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Biote Current Valuation Historical Pattern
Today, most investors in Biote Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Biote Corp's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Biote Corp current valuation as a starting point in their analysis.
Biote Corp Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, biote Corp has a Current Valuation of 276.98 M. This is 98.07% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 98.33% higher than that of the company.
biote Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biote Corp's current stock value. Our valuation model uses many indicators to compare Biote Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biote Corp competition to find correlations between indicators driving Biote Corp's intrinsic value. More Info.biote Corp is number one stock in return on asset category among its peers. It is rated fifth in profit margin category among its peers fabricating about 0.20 of Profit Margin per Return On Asset. The ratio of Return On Asset to Profit Margin for biote Corp is roughly 4.88 . At present, Biote Corp's Net Profit Margin is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Biote Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Biote Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biote Corp's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biote Corp could also be used in its relative valuation, which is a method of valuing Biote Corp by comparing valuation metrics of similar companies.Biote Corp is currently under evaluation in current valuation category among its peers.
Biote Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of Biote Corp from analyzing Biote Corp's financial statements. These drivers represent accounts that assess Biote Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Biote Corp's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Enterprise Value | 101.3M | 84.8M | 71.3M | 152.9M | 137.6M | 83.7M |
Biote Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Biote Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Biote Corp's managers, analysts, and investors.Environmental | Governance | Social |
Biote Fundamentals
| Return On Asset | 0.18 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 276.98 M | ||||
| Shares Outstanding | 31.11 M | ||||
| Shares Owned By Insiders | 27.00 % | ||||
| Shares Owned By Institutions | 64.62 % | ||||
| Number Of Shares Shorted | 748.23 K | ||||
| Price To Earning | 0.26 X | ||||
| Price To Book | 2.96 X | ||||
| Price To Sales | 1.69 X | ||||
| Revenue | 185.36 M | ||||
| Gross Profit | 90.58 M | ||||
| EBITDA | 9.23 M | ||||
| Net Income | 3.32 M | ||||
| Cash And Equivalents | 82.72 M | ||||
| Cash Per Share | 1.22 X | ||||
| Total Debt | 114.87 M | ||||
| Debt To Equity | 3.36 % | ||||
| Current Ratio | 3.23 X | ||||
| Book Value Per Share | (4.19) X | ||||
| Cash Flow From Operations | 26.88 M | ||||
| Short Ratio | 3.89 X | ||||
| Earnings Per Share | 0.30 X | ||||
| Target Price | 9.95 | ||||
| Number Of Employees | 194 | ||||
| Beta | 0.94 | ||||
| Market Capitalization | 327.05 M | ||||
| Total Asset | 155.29 M | ||||
| Retained Earnings | (29.39 M) | ||||
| Working Capital | 100.13 M | ||||
| Net Asset | 155.29 M |
About Biote Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze biote Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biote Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of biote Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 3.5 M | 2.4 M | |
| Total Revenue | 213.2 M | 157.6 M | |
| Cost Of Revenue | 66.6 M | 54.9 M | |
| Stock Based Compensation To Revenue | 0.06 | 0.05 | |
| Sales General And Administrative To Revenue | 0.90 | 0.95 | |
| Capex To Revenue | 0.02 | 0.02 | |
| Revenue Per Share | 8.29 | 7.88 | |
| Ebit Per Revenue | 0.18 | 0.11 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Biote Corp Piotroski F Score and Biote Corp Altman Z Score analysis. For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biote Corp. If investors know Biote will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biote Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.375 | Earnings Share 0.3 | Revenue Per Share | Quarterly Revenue Growth 0.128 | Return On Assets |
The market value of biote Corp is measured differently than its book value, which is the value of Biote that is recorded on the company's balance sheet. Investors also form their own opinion of Biote Corp's value that differs from its market value or its book value, called intrinsic value, which is Biote Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biote Corp's market value can be influenced by many factors that don't directly affect Biote Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biote Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biote Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.